BLOOMAGE BIOTECHNOLOGY CORP LTD Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
華 熙 生 物 科 技 有 限 公 司
(incorporated in the Cayman Islands with limited liability)
(Stock Code: 00963)The Board announces the following changes with effect from 18 January 2016:
Mr. Guo has resigned as a non-executive Director and an Authorised Representative;
Mr. Yau has been appointed as a non-executive Director, the Company Secretary and an Authorised Representative;
Mr. Hai has resigned as an independent non-executive Director, member of the Audit Committee and the Nomination Committee and the chairman of the Remuneration Committee;
Mr. Xue has been appointed as an independent non-executive Director, member of the Audit Committee and the Nomination Committee and the chairman of the Remuneration Committee;
Mr. Loong has resigned as the Company Secretary and an Authorised Representative;
Ms. Wang has been appointed as an Authorised Representative; and
The Company's principal place of business has been changed to Room 501, Hutchison House, No 10 Harcourt Road, Central, Hong Kong.
The board (the "Board") of directors (the "Directors") of Bloomage BioTechnology Corporation Limited (the "Company", together with its subsidiaries, the "Group") announces that Mr. Guo Jiajun ("Mr. Guo") has resigned as a non-executive Director with effect from 18 January 2016 due to his other business commitments which require more of his dedications.
Mr. Guo has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.
The Board further announces that Mr. Hai Wen ("Mr. Hai") has resigned as an independent non-executive Director, member of the audit committee (the "Audit Committee") and nomination committee (the "Nomination Committee") and the chairman of the remuneration committee (the "Remuneration Committee") of the Company with effect from 18 January 2016 due to pursuit of his own career development.
Mr. Hai has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.
APPOINTMENT OF NON-EXECUTIVE DIRECTOR Mr. Yau Wai Yan (邱偉仁)The Board is please to announce that Mr. Yau Wai Yan ("Mr. Yau") has been appointed as a non-executive Director with effect from 18 January 2016.
Set out below is the biography of Mr. Yau.
Mr. Yau, aged 40, is the financial controller and company secretary of the Company. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants. Mr. Yau graduated from the Hong Kong University of Science and Technology with a bachelor's degree in professional accounting. Prior to joining the Company, Mr. Yau had worked for an international accounting firm for over 10 years, and has extensive experience in finance and accounting. Mr. Yau is a director of a subsidiary of the Company.
As at the date of this announcement, Mr. Yau is beneficially interested in 242,188 shares of the Company and the 99,600 shares of the Company which may be allotted and issued to him upon full exercise of the options granted to him under the share option scheme of the Company.
Save as disclosed above, Mr. Yau does not hold any directorship in other public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years or any other position with the Company and other members of the Group or other major appointments and professional qualifications.
Save as disclosed above, Mr. Yau does not have any relationship with other Directors, senior management, substantial or controlling shareholders of the Company and he has no interests in the shares of the Company which are required to be disclosed pursuant to Part XV of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) (the "SFO").
Mr. Yau will enter into a director's service agreement with the Company for a term of three years commencing on 18 January 2016 subject to rotation and re-election at annual general meetings of the Company in accordance with the articles of association of the Company. The service agreement can be terminated by either party by giving the other party one month written notice in advance. The director's remuneration of Mr. Yau is HK$100,000 per annum and Mr. Yau will be entitled to discretionary bonus payment subject to approval of the Board (subject to final confirmation upon execution of the relevant service agreement). The said emoluments are determined with reference to his duties and responsibilities within the Company.
Save as disclosed above, there are no other matters relating to the appointment of Mr. Yau that need to be brought to the attention of the shareholders of the Company and there is no other information that should be disclosed pursuant to paragraphs 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").
The Board is pleased to announce that Mr. Xue Zhaofeng ("Mr. Xue") has been appointed as an independent non-executive Director with effect from 18 January 2016.
Set out below is the biography of Mr. Xue.
Mr. Xue, aged 48, holds a doctorate of philosophy (PhD) in economics from George Mason University and was a postdoctoral fellow at Northwestern University School of Law from 2008 to 2010. Mr. Xue is currently a professor at National School of Development and a co-director of the Institute for Law and Economics, Peking University.
In 2006, Mr. Xue was awarded the title of "Youth of the Year" by Southern People Magazine. Mr. Xue is a member of "Information Society 50 Forum" (信息社會50人 論壇), a co-founding member of "Micro-Finance 50 Forum" (微金融50人論壇) and the invited-economist of Alibaba Inc.. Mr. Xue is also the author of various books, including "Global Trend: The Modularized Innovation and the New Opportunity of China" (全球風口 - 積木式創新與中國新機會), "Common Sense in Economics" (經 濟學通識) and "Commerce without Frontiers: The Economics Revolution in Antitrust" (商業無邊界 - 反壟斷法的經濟學革命).
Save as disclosed above, Mr. Xue does not hold any directorship in other public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years or any other position with the Company and other members of the Group or other major appointments and professional qualifications.
Mr. Xue does not have any relationship with other Directors, senior management, substantial or controlling shareholders of the Company and he has no interests in the shares of the Company which are required to be disclosed pursuant to Part XV of the SFO.
Mr. Xue will enter into a director's service agreement with the Company for a term of three years commencing on 18 January 2016 subject to rotation and re-election at annual general meetings of the Company in accordance with the articles of
Bloomage BioTechnology Corporation Ltd. issued this content on 2016-01-18 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-18 14:40:03 UTC
Original Document: http://www.bloomagebio-tech.com/attachment/2016011822020100002414117_en.pdf
